ClinicalTrials.Veeva

Menu

Clinical Outcomes From Patient Self-management of Antivitamin K Treatment (ORION)

F

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Status

Completed

Conditions

Self Management of Oral Anticoagulation With VKA Therapy

Treatments

Device: Patient Self-Management of VKA therapy

Study type

Observational

Funder types

Other

Identifiers

NCT03532724
IIBSP-ORI-2017-45

Details and patient eligibility

About

ORION is a retrospective, observational, one center study to evaluate the incidence of complications (both thromboembolic and bleedings) in a cohort of patients receiving Vitamin K antagonists (VKA) under a self-management program, since 2002 at the Hospital de la Santa Creu i Sant Pau in Barcelona (Spain)

Enrollment

927 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adult patients (older than 18) under chronic VKA treatment, whom performed patient self-management for any indication of oral anticoagulation.
  2. Signed informed consent

Exclusion criteria

  1. Patients younger than 18 years old

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems